E1	Condition:T1 Name:T2
E3	Condition:T3 Name:T4
E5	Condition:T5 Name:T6
E7	Condition:T7 Name:T8
E9	Condition:T9 Name:T10
E11	Condition:T11 Name:T12 Severity:T95
E13	Condition:T13 Name:T14
E15	Condition:T15 Name:T16 Temporality:E46 Temporality2:E42
E17	Condition:T17 Name:T18
E19	Condition:T19 Name:T20 Severity:T100
E21	Condition:T21 Name:T22 Temporality:E45
E26	Condition:T26 Name:T27
E28	Condition:T28 Name:T29
E30	Condition:T30 Name:T31
E32	Condition:T32 Name:T33 Temporality:E44
E34	Condition:T34 Name:T35
E36	Condition:T36 Name:T37
E38	Condition:T38 Name:T39
E40	Condition:T40 Name:T41
E41	Age:T45 Eq-Comparison:E43
E42	Eq-Comparison:T50 Operator:T42 Temporal-Unit:T44 Value:T49
E43	Eq-Comparison:T51 Operator:T46 Value:T47 Value2:T48 Temporal-Unit:T43
E44	Eq-Comparison:T52 Temporal-Period:T53
E45	Eq-Comparison:T54 Temporal-Period:T55
E46	Eq-Comparison:T56 Temporal-Period:T57
E2	Or:T58 Arg:T25 Arg2:T23
E4	And:T59 Arg:E41 Arg2:E3
E6	Assertion:T60 Asserted:E32
E8	Condition:T61 Name:T62
E10	Criteria-Count:T63 Min-Value:E12 Criteria:E8 Criteria2:E1 Criteria3:E34 Criteria4:E36
E12	Eq-Comparison:T64 Value:T65
E14	Or:T66 Arg:E26 Arg2:E1
E16	Modifier:T67 Modifies:T2
E18	Condition:T68 Name:T69
E20	Criteria-Count:T70 Min-Value:E22 Criteria:E13 Criteria2:E5 Criteria3:E17 Criteria4:E7
E22	Eq-Comparison:T71 Value:T72
E23	Or:T73 Arg:E5 Arg2:E17
E24	Or:T74 Arg:E17 Arg2:E7
E25	Modifier:T75
E27	Drug:T76 Name:T77
E29	Drug:T78 Name:T79
E31	Or:T80 Arg:E27 Arg2:E29
E33	Observation:T81 Name:T82
E35	Observation:T83 Name:T84 Eq-Comparison:E37
E37	Eq-Comparison:T85 Unit:T86 Operator:T87 Value:T88 Value2:T89
E39	Condition:T90 Name:T91
E47	Condition:T92 Name:T93
E48	Or:T94 Arg:E47 Arg2:E33
E49	Condition:T96 Name:T97
E50	Or:T98 Arg:E11 Arg2:E49
E51	Modifier:T99 Modifies:T22
E52	Or:T101 Arg:E21 Arg2:E19
E53	Modifier:T102 Modifies:T16
E54	Study:T103
E55	Temporal-Connection:T104 Arg:E42 Arg2:E54
E56	Encounter:T105 Type:T106
E57	Drug:T107
E58	Or:T108 Arg:E38 Arg2:E57
E59	Other:T109 Is-Other:E57
T1	Condition 247 278	pulmonary arterial hypertension
T2	Condition-Name 247 278	pulmonary arterial hypertension
T3	Condition 88 119	pulmonary arterial hypertension
T4	Condition-Name 88 119	pulmonary arterial hypertension
T5	Condition 403 434	mixed connective tissue disease
T6	Condition-Name 403 434	mixed connective tissue disease
T7	Condition 468 487	lupus erythematosus
T8	Condition-Name 468 487	lupus erythematosus
T9	Condition 337 363	connective tissue diseases
T10	Condition-Name 337 363	connective tissue diseases
T11	Condition 709 730	systemic hypertension
T12	Condition-Name 709 730	systemic hypertension
T13	Condition 382 401	limited scleroderma
T14	Condition-Name 382 401	limited scleroderma
T15	Condition 863 882	right heart failure
T16	Condition-Name 863 882	right heart failure
T17	Condition 438 454	overlap syndrome
T18	Condition-Name 438 454	overlap syndrome
T19	Condition 817 832	cardiac disease
T20	Condition-Name 817 832	cardiac disease
T21	Condition 773 786	heart disease
T22	Condition-Name 773 786	heart disease
T23	Life-Stage-And-Gender 42 49	females
T24	Life-Stage-And-Gender 25 30	Adult
T25	Life-Stage-And-Gender 32 37	males
T26	Condition 228 232	IPAH
T27	Condition-Name 228 232	IPAH
T28	Condition 280 284	HPAH
T29	Condition-Name 280 284	HPAH
T30	Condition 121 124	PAH
T31	Condition-Name 121 124	PAH
T32	Condition 166 169	PAH
T33	Condition-Name 166 169	PAH
T34	Condition 296 299	PAH
T35	Condition-Name 296 299	PAH
T36	Condition 498 501	PAH
T37	Condition-Name 498 501	PAH
T38	Condition 938 941	PAH
T39	Condition-Name 938 941	PAH
T40	Condition 975 978	PAH
T41	Condition-Name 975 978	PAH
T42	Eq-Operator 883 889	within
T43	Eq-Temporal-Unit 65 70	years
T44	Eq-Temporal-Unit 893 897	days
T45	Age 51 55	aged
T46	Eq-Operator 59 61	to
T47	Eq-Value 56 58	18
T48	Eq-Value 62 64	75
T49	Eq-Value 890 892	30
T50	Eq-Comparison 883 897	within 30 days
T51	Eq-Comparison 56 70	18 to 75 years
T52	Eq-Comparison 133 140	current
T53	Eq-Temporal-Period 133 140	current
T54	Eq-Comparison 751 758	History
T55	Eq-Temporal-Period 751 758	History
T56	Eq-Comparison 838 845	History
T57	Eq-Temporal-Period 838 845	History
T58	Or 38 41	and
T59	And 83 87	with
T60	Assertion 154 165	symptomatic
T61	Condition 216 226	Idiopathic
T62	Condition-Name 216 226	Idiopathic
T63	Criteria-Count 191 204	the following
T64	Eq-Comparison 184 187	one
T65	Eq-Value 184 187	one
T66	Or 234 236	or
T67	Modifier 237 246	heritable
T68	Condition 365 369	CTDs
T69	Condition-Name 365 369	CTDs
T70	Criteria-Count 323 336	the following
T71	Eq-Comparison 316 319	one
T72	Eq-Value 316 319	one
T73	Or 435 437	or
T74	Or 456 458	or
T75	Modifier 459 467	systemic
T76	Drug 518 528	anorexigen
T77	Drug-Name 518 528	anorexigen
T78	Drug 532 547	methamphetamine
T79	Drug-Name 532 547	methamphetamine
T80	Or 529 531	or
T81	Observation 589 615	New York Heart Association
T82	Observation-Name 589 615	New York Heart Association
T83	Observation 617 621	NYHA
T84	Observation-Name 617 621	NYHA
T85	Eq-Comparison 634 645	class II-IV
T86	Eq-Unit 634 639	class
T87	Eq-Operator 642 643	-
T88	Eq-Value 640 642	II
T89	Eq-Value 643 645	IV
T90	Condition 557 582	World Health Organization
T91	Condition-Name 557 582	World Health Organization
T92	Condition 584 587	WHO
T93	Condition-Name 584 587	WHO
T94	Or 588 589	/
T95	Severity 697 708	significant
T96	Condition 734 745	hypotension
T97	Condition-Name 734 745	hypotension
T98	Or 731 733	or
T99	Modifier 762 772	left-sided
T100	Severity 805 816	significant
T101	Or 787 793	and/or
T102	Modifier 849 862	decompensated
T103	Study 901 910	screening
T104	Temporal-Connection 898 900	of
T105	Encounter 918 933	hospitalization
T106	Encounter-Type 918 933	hospitalization
T107	Drug 979 989	medication
T108	Or 942 944	or
T109	Other 964 974	additional
A1	Life-Stage-And-Gender-Type T23 female
A2	Life-Stage-And-Gender-Type T24 adult
A3	Life-Stage-And-Gender-Type T25 male
A4	Eq-Operator-Value T42 LTEQ
A5	Eq-Temporal-Unit-Value T43 year
A6	Eq-Temporal-Unit-Value T44 day
A7	Eq-Operator-Value T46 BETWEEN
A8	Eq-Temporal-Period-Value T53 present
A9	Eq-Temporal-Period-Value T55 past
A10	Eq-Temporal-Period-Value T57 past
A11	Assertion-Type-Value E6 possible
A12	Eq-Operator-Value T87 BETWEEN
A13	Severity-Value T95 severe
A14	Severity-Value T100 severe
A15	Temporal-Connection-Type-Value E55 before
A16	Encounter-Type-Value T106 inpatient
A17	Observation-Type-Value T82 clinical-score
A18	Observation-Type-Value T84 clinical-score
R1	Abbrev-Of Arg1:E30 Arg2:E3
R2	Abbrev-Of Arg1:E26 Arg2:E8
R3	Abbrev-Of Arg1:E28 Arg2:E1
R4	Abbrev-Of Arg1:E18 Arg2:E9
R5	Caused-By Arg1:E34 Arg2:E9
R6	Abbrev-Of Arg1:E25 Arg2:E7
R7	Caused-By Arg1:E36 Arg2:E27
R8	Abbrev-Of Arg1:E35 Arg2:E33
R9	Abbrev-Of Arg1:E47 Arg2:E39
R10	Treatment-For Arg1:E56 Arg2:E38
R11	Example-Of Arg1:E56 Arg2:E15
R12	Treatment-For Arg1:E57 Arg2:E40